Health DiagnosticsImmunologyAllergyBiotechnologyHealth CareMedicalPharmaceutical
Description
ALK-Abelló A/S operates as an allergy solutions company.
Products and Services
The company offers a diverse range of products and services centered on allergy treatment through immunotherapy. The primary product lines include allergen immunotherapy…
Analysis
Beloved champion
ALK-Abelló A/S is a beloved champion: its quality is genuine, and the market already prices it as exceptional.
The price is expensive. You pay 46.9× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 18% yearly growth; analysts expect 15%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is sturdy. The company scores 20/20 on our value-creation score: strong value creator.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202330
94
2023202420252026
All-time high
94
Jun 2026
All-time low
30
Jan 2023
Average rank
66
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
23
7
22
15
Price/Earnings
5
9
12
3
Price/Book
10
1
14
3
Dividend Yield
63
1
1
1
Value (overall)
15
1
5
1
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.